Open-label use of an aliphatic polyamine immunomodulator in patients hospitalized with COVID-19.
Efimov SV, Matsiyeuskaya NV, Boytsova OV, Akhieva LY, Kuntsevich EV, Troshina AA, Kvasova EI, Tikhonov AA, Khomyakova NF, Harrison F, Rossi JF, Hardman TC.
Efimov SV, et al.
Drugs Context. 2022 Mar 3;11:2022-1-1. doi: 10.7573/dic.2022-1-1. eCollection 2022.
Drugs Context. 2022.
PMID: 35310299
Free PMC article.